Saxena, R.

stroke patient dclhb ischemic stroke study ischemic treatment trial effect group blood atrial fibrillation hemoglobin atrial heparin fibrillation diaspirin cross-linked hemoglobin chapter pressure recurrence randomized increase blood pressure outcome diaspirin aspirin event 14 days stroke patients plasma heart cross-linked baseline 24 hours prevention infusion brain phase stroke trial death patienten saline table placebo control value safety infarct result concentration ischemia month hypertension 3 months hemorrhagic pressor effect endothelin cause pressor infarction solution response factor anticoagulant analysis history hemorrhage embolism przybelski rj 66 hours diaspirin crosslinked hemoglobin animal onset oxygen therapy symptom nitric oxide monitoring koudstaal pj heart rate